College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value

Daniel Rhoads; David R. Peaper; Rosemary C. She; Frederick S. Nolte; Christina M. Wojewoda; Neil W. Anderson; Bobbi S. Pritt

doi:10.1093/cid/ciaa1199

College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value

Daniel Rhoads
, David R. Peaper
, Rosemary C. She
, Frederick S. Nolte
, Christina M. Wojewoda
, Neil W. Anderson
, Bobbi S. Pritt

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E685-E686
Journal	Clinical Infectious Diseases
Volume	72
Issue number	10
DOIs	https://doi.org/10.1093/cid/ciaa1199
State	Published - May 15 2021

Access to Document

10.1093/cid/ciaa1199

Cite this

@article{71cb5f39fed14449824d4cf7c5b6bd15,

title = "College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value",

author = "Daniel Rhoads and Peaper, \{David R.\} and She, \{Rosemary C.\} and Nolte, \{Frederick S.\} and Wojewoda, \{Christina M.\} and Anderson, \{Neil W.\} and Pritt, \{Bobbi S.\}",

note = "Funding Information: Potential conflicts of interest. N. W. A. reports being on the Scientific Advisory Board of Diasorin Molecular; F. S. N. reports honoraria from Abbott Molecular; D. R. reports receiving research funding on novel antibacterial agents through Shionogi Inc., Tetraphase pharmaceuticals Inc., and VenatoRx pharmaceuticals; grants from BD, Roche, BioFire, and OpGen; Advisory Board for Luminex; and speaker fees for BD; R. C. S. reports honoraria from BioFire. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.",

year = "2021",

month = may,

day = "15",

doi = "10.1093/cid/ciaa1199",

language = "English",

volume = "72",

pages = "E685--E686",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "10",

}

TY - JOUR

T1 - College of American Pathologists (CAP) Microbiology Committee Perspective

T2 - Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value

AU - Rhoads, Daniel

AU - Peaper, David R.

AU - She, Rosemary C.

AU - Nolte, Frederick S.

AU - Wojewoda, Christina M.

AU - Anderson, Neil W.

AU - Pritt, Bobbi S.

N1 - Funding Information: Potential conflicts of interest. N. W. A. reports being on the Scientific Advisory Board of Diasorin Molecular; F. S. N. reports honoraria from Abbott Molecular; D. R. reports receiving research funding on novel antibacterial agents through Shionogi Inc., Tetraphase pharmaceuticals Inc., and VenatoRx pharmaceuticals; grants from BD, Roche, BioFire, and OpGen; Advisory Board for Luminex; and speaker fees for BD; R. C. S. reports honoraria from BioFire. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

PY - 2021/5/15

Y1 - 2021/5/15

UR - https://www.scopus.com/pages/publications/85107082789

U2 - 10.1093/cid/ciaa1199

DO - 10.1093/cid/ciaa1199

M3 - Letter

C2 - 32785682

AN - SCOPUS:85107082789

SN - 1058-4838

VL - 72

SP - E685-E686

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value

Access to Document

Other files and links

Cite this